english Icono del idioma   español Icono del idioma  

Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/20.500.12008/56117 Cómo citar
Título: Challenges in institutional ethical review process and approval for international multicenter clinical studies in lower and middle-income countries: the case of PARITY study
Autor: Lopez-Baron, Eliana
Abbas, Qalab
Caporal, Paula
González-Dambrauskas, Sebastián
Tipo: Artículo
Palabras clave: IRBs, Institutional Review Boards, Challenges, Ethics, Global, Low- and middle-income countries, Research
Descriptores: COMITÉS DE ÉTICA EN INVESTIGACIÓN, PAÍSES EN DESARROLLO, ÉTICA, INVESTIGACIÓN, INVESTIGACIÓN INTERDISCIPLINARIA, EVALUACIÓN DE LA INVESTIGACIÓN EN SALUD
Fecha de publicación: 2024
Resumen: Background: One of the greatest challenges to conducting multicenter research studies in low and middle-income countries (LMICs) is the heterogeneity in regulatory processes across sites. Previous studies have reported variations in requirements with a lack of standardization in the Institutional Review Board (IRB) processes between centers, imposing barriers for approval, participation, and development of multicenter research. Objectives: To describe the regulatory process, variability and challenges faced by pediatric researchers in LMICs during the IRB process of an international multicenter observational point prevalence study (Global PARITY). Design: A 16-question multiple-choice online survey was sent to site principal investigators (PIs) at PARITY study participating centers to explore characteristics of the IRB process, costs, and barriers to research approval. A shorter survey was employed for sites that expressed interest in participating in Global PARITY and started the approval process, but ultimately did not participate in data collection (non-participating sites) to assess IRB characteristics. Results: Of the 91 sites that sought IRB approval, 46 were successful in obtaining approval and finishing the data collection process. The survey was completed by 46 (100%) participating centers and 21 (47%) non-participating centers. There was a significant difference between participating and non-participating sites in IRB approval of a waiver consent and in the requirement for a legal review of the protocol. The greatest challenge to research identified by non-participating sites was a lack of research time and the lack of institutional support. Conclusions: Global collaborative research is crucial to increase our understanding of pediatric critical care conditions in hospitals of all resource-levels and IRBs are required to ensure that this research complies with ethical standards. Critical barriers restrict research activities in some resource limiting countries. Increasing the efficiency and accessibility of local IRB review could greatly impact participation of resource limited sites and enrollment of vulnerable populations.
Descripción: Eliana Lopez-Baron 1 2, Qalab Abbas 3, Paula Caporal 4 5, Asya Agulnik 6 7, Jonah E Attebery 8, Adrian Holloway 9, Niranjan Tex Kissoon 10 11, Celia Isabel Mulgado-Aguas 12, Kokou Amegan-Aho 13, Marianne Majdalani 14, Carmen Ocampo 15, Havugarurema Pascal 16, Erika Miller 9, Aimable Kanyamuhunga 17, Atnafu Mekonnen Tekleab 18, Tigist Bacha 18, Sebastian González-Dambrauskas 19 20, Adnan T Bhutta 21, Teresa B Kortz 22 23, Srinivas Murthy 24, Kenneth E Remy 25; Global Health Subgroup of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network
Affiliations 1Departamento de Pediatría y Cuidado Crítico Pediátrico, Hospital Pablo Tobón Uribe, Universidad EIA, Medellín, Colombia. 2Departamento de Pediatría, Universidad de Antioquia, Medellín, Colombia. 3Department of Pediatrics and Child Health, Aga Khan University Hospital, Karachi, Pakistan. 4Health Systems Program, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. 5Red Colaborativa Pediátrica de Latinoamérica (LARed Network), La Plata, Argentina. 6Division of Critical Care and Pulmonary Medicine, Department of Pediatrics, St Jude Children's Research Hospital, Memphis, TN, United States. 7Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN, United States. 8Department of Neurosurgery, Barrow Global, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States. 9Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, United States. 10Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada. 11Division of Critical Care, British Columbia Children's Hospital, Vancouver, BC, Canada. 12Unidad de Terapia Intensiva Pediátrica, Hospital General León, León, México. 13Department of Pediatrics and Child Health, School of Medicine, University of Health and Allied Sciences, Ho, Ghana. 14Division of Pediatric Intensive Care Unit, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon. 15Grupo Quirón Salud, Clínica Imbanaco, Cali, Colombia. 16Department of Pediatrics and Child Health, University Teaching Hospital of Butare, Butare, Rwanda. 17Department of Pediatrics and Child Health, University Teaching Hospital of Kigali, Kigali, Rwanda. 18Department of Pediatrics and Child Health, St. Paul's Hospital Millennium Hospital Medical College, Addis Ababa, Ethiopia. 19Red Colaborativa Pediátrica de Latinoamérica (LARed Network), Montevideo, Uruguay. 20Departamento de Pediatría y Unidad de Cuidados Intensivos de Niños del Centro Hospitalario Pereira Rossell, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay. 21Division of Pediatric Critical Care Medicine, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IA, United States. 22Division of Critical Care, Department of Pediatrics, University of California, San Francisco, CA, United States. 23Institute for Global Health Sciences, UCSF, San Francisco, CA, United States. 24Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada. 25Division of Pediatric Critical Care Medicine, Department of Pediatrics, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, OH, United States.
Editorial: Frontiers Media
EN: Frontiers in Pediatrics. 2024;12
Citación: Lopez-Baron E, Abbas Q, Caporal P y otros. Challenges in institutional ethical review process and approval for international multicenter clinical studies in lower and middle-income countries: the case of PARITY study. Frontiers in Pediatrics [en línea]. 2024;12. 7 p.
Licencia: Licencia Creative Commons Atribución (CC - By 4.0)
Aparece en las colecciones: Publicaciones Académicas y Científicas - Facultad de Medicina

Ficheros en este ítem:
Fichero Descripción Tamaño Formato   
Challenges in institutional ethical review process and approval.pdfChallenges in institutional ethical review process and approval13,12 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons